ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026
Preclinical Characterization of CLSP-1025, a First-in-Class, Mutation-Specific T-Cell Engager Targeting a Neoantigen Derived from a Common p53 Mutation.
Michael F Maloney et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.